Swiss National Bank Repare Therapeutics Inc. Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$9.32 - $15.06 $44,736 - $72,288	-4,800 Reduced 10.55%	40,700 $400,000
Q4 2022 Feb 08, 2023	BUY	$12.5 - $18.13 $15,000 - $21,756	1,200 Added 2.71%	45,500 $669,000
Q2 2022 Aug 09, 2022	BUY	$8.45 - $14.84 $40,560 - $71,232	4,800 Added 12.15%	44,300 $620,000
Q1 2022 May 09, 2022	BUY	$11.38 - $21.88 $29,588 - $56,888	2,600 Added 7.05%	39,500 $562,000
Q4 2021 Feb 08, 2022	BUY	$19.66 - $28.11 $316,526 - $452,571	16,100 Added 77.4%	36,900 $778,000
Q4 2020 Feb 05, 2021	BUY	$23.42 - $39.5 $487,136 - $821,600	20,800 New	20,800 $713,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.